LAMP1 and hepatocellular carcinoma: Moreover, the immunogenic peptides originating from neoantigens in hepatocellular carcinoma organoids and tissue were determined by the increased CD107a and IFN-γ by CD8+ T cells from healthy donor PBMCs [40].